OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

1.97
Delayed Data
As of May 01
 -0.04 / -1.99%
Today’s Change
1.77
Today|||52-Week Range
4.33
-13.97%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$44.7M

Company Description

OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company. It develops and commercializes new cancer therapies that address treatment resistance in cancer patients. The company has three product candidates in development: Custirsen, OGX-427 and OGX-225. OncoGenex Pharmaceuticals was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.

Contact Information

OncoGenex Pharmaceuticals, Inc.
1522-217th Place SE
Bothell Washington 98021
P:(425) 686-1500
Investor Relations:
(425) 686-1535

Employees

Shareholders

Individual stakeholders5.92%
Other institutional27.71%
Mutual fund holders11.20%

Top Executives

Scott Daniel CormackPresident, CEO, Secretary, Treasurer & Director
John A. BencichChief Financial Officer & Vice President
Patricia S. StewartVice President-Clinical Development
Cindy A. JacobsChief Medical Officer & Executive Vice President
Jaime WelchVP-Marketing & Corporate Communications

To view my watchlist

Not a member yet?

Sign up now for a free account